Mir M, Altuhami S, Mondal S, Bashir N, Dera A, Alfhili M
Antibiotics (Basel). 2023; 12(3).
PMID: 36978443
PMC: 10044350.
DOI: 10.3390/antibiotics12030576.
McClure C, Bollen M, Buttolph L, Stack E, Langley B, Hanes D
Adv Integr Med. 2023; 9(3):159-166.
PMID: 36960315
PMC: 10032363.
DOI: 10.1016/j.aimed.2022.04.003.
El-Hawary S, Mohammed R, Taher M, AbouZid S, Mansour M, Almahmoud S
Plants (Basel). 2022; 11(7).
PMID: 35406868
PMC: 9002841.
DOI: 10.3390/plants11070888.
Akhtar M
Front Pharmacol. 2022; 13:809324.
PMID: 35401207
PMC: 8987533.
DOI: 10.3389/fphar.2022.809324.
Dechayont B, Phuaklee P, Chunthorng-Orn J, Juckmeta T, Prajuabjinda O, Jiraratsatit K
BMC Complement Med Ther. 2021; 21(1):105.
PMID: 33785002
PMC: 8010956.
DOI: 10.1186/s12906-021-03274-6.
The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes.
Ryan R, Fernandez A, Wong Y, Miles J, Cock I
Sci Rep. 2021; 11(1):5519.
PMID: 33750911
PMC: 7970899.
DOI: 10.1038/s41598-021-85211-8.
Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms.
Strauch M, Tomaz M, Monteiro-Machado M, Cons B, Patrao-Neto F, Teixeira-Cruz J
PLoS One. 2019; 14(1):e0211229.
PMID: 30689661
PMC: 6349327.
DOI: 10.1371/journal.pone.0211229.
Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.
Babu M, Mahanta S, Lakhter A, Hato T, Paul S, Naidu S
PLoS One. 2018; 13(2):e0191419.
PMID: 29394289
PMC: 5796696.
DOI: 10.1371/journal.pone.0191419.
β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers.
Yang Y, Zhou X, Xu M, Piao J, Zhang Y, Lin Z
Sci Rep. 2017; 7(1):2681.
PMID: 28578385
PMC: 5457413.
DOI: 10.1038/s41598-017-02937-0.
ANTHELMINTIC ACTIVITY OF LAPACHOL, β-LAPACHONE AND ITS DERIVATIVES AGAINST Toxocara canis LARVAE.
Mata-Santos T, Pinto N, Mata-Santos H, De Moura K, Carneiro P, Carvalho T
Rev Inst Med Trop Sao Paulo. 2015; 57(3):197-204.
PMID: 26200958
PMC: 4544242.
DOI: 10.1590/S0036-46652015000300003.
Effects of the serjania erecta and zeyheria montana ethanol extracts in experimental pulpitis in rats: a histological study.
Nossa P, Guenka L, Couto L, da-Cruz-Perez D
Med Oral Patol Oral Cir Bucal. 2012; 18(2):e337-42.
PMID: 23229264
PMC: 3613889.
DOI: 10.4317/medoral.18470.
Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (β-lapachone).
Sitonio M, Carvalho Junior C, Campos I, Silva J, de Lima M, Goes A
Inflamm Res. 2012; 62(1):107-13.
PMID: 23052183
DOI: 10.1007/s00011-012-0557-0.
Systematic review of herbals as potential anti-inflammatory agents: Recent advances, current clinical status and future perspectives.
Beg S, Swain S, Hasan H, Barkat M, Hussain M
Pharmacogn Rev. 2012; 5(10):120-37.
PMID: 22279370
PMC: 3263046.
DOI: 10.4103/0973-7847.91102.
Development of lapachol topical formulation: anti-inflammatory study of a selected formulation.
Lira A, Sester E, Carvalho A, Strattmann R, Albuquerque M, Wanderley A
AAPS PharmSciTech. 2008; 9(1):163-8.
PMID: 18446477
PMC: 2976889.
DOI: 10.1208/s12249-007-9002-z.
Oxyrane derivative of alpha-lapachone is potent growth inhibitor of Trypanosoma cruzi epimastigote forms.
Jorqueira A, Gouvea R, Ferreira V, da Silva M, de Souza M, Zuma A
Parasitol Res. 2006; 99(4):429-33.
PMID: 16596415
DOI: 10.1007/s00436-006-0153-8.
Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract.
de Miranda F, Vilar J, Alves I, Cavalcanti S, Antoniolli A
BMC Pharmacol. 2001; 1:6.
PMID: 11574048
PMC: 56902.
DOI: 10.1186/1471-2210-1-6.
